1
|
Muhumuza D, Coiquaud R, Lechaux-Clément C, Loubrieu V. Le pharmacien en première ligne pour accompagner les fumeurs vers le sevrage tabagique. ACTUALITES PHARMACEUTIQUES 2021. [DOI: 10.1016/j.actpha.2021.08.014] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/26/2022]
|
2
|
Le Faou AL, Allagbé I, Airagnes G, Baha M, Boussadi A, Limosin F. Predictors of Smoking Cessation Attempt and Continued Abstinence among Low-Income Disabled Smokers: Evidence from the French National Smoking Cessation Cohort CDT-Net. Subst Use Misuse 2020; 55:1724-1731. [PMID: 32423276 DOI: 10.1080/10826084.2020.1759644] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 10/24/2022]
Abstract
Background: In France, daily smoking has been highly prevalent among low-income smokers.Objectives: Our aim was to search for factors associated with both continued abstinence and attempting to quit among low-income disabled smokers. Methods: From the French national smoking cessation cohort CDT-net, we included 1624 adults living with disability pension or disabled adult allowance. Our dependent variables (abstainers, attempting to quit among non-abstainers) were used in logistic regressions. Continued abstinence was defined as self-reports of no smoking for more than 28 days and attempting to quit was defined as self-reports of no smoking for less than 28 days; both validated with carbon monoxide < 10 ppm. Results: The average age was 48.5 years, with a predominance of men (55.5%). Achieved continued abstinence was 29.9% and was positively associated with age ≥ 55, history of previous attempts, low-dependence, and number of consultations during follow-up (all p < .05). Depression history, anxiety symptoms and cannabis use were negatively associated with continued abstinence (p < .05). Quit attempts were associated with lower dependence and number of consultations during follow-up. Pharmacological treatments prescribed at inception did not contribute to improve continued abstinence rates but varenicline was found to increase quit attempts unless the number of prescriptions was scarce. Conclusion: Even among low-income disabled smokers, achieving continued abstinence and attempting to quit could be promoted with similar predictors than among affluent smokers. Treatment of anxiety symptoms and specific support for smokers with a depression history could be included in the follow-up of quit attempts.
Collapse
Affiliation(s)
- Anne-Laurence Le Faou
- Department of Psychiatry and Addictology, AP-HP. Centre, Université de Paris, Paris, France.,Fédération Hospitalo-Universitaire, Network of Research in Substance Use Disorder, AP-HP, Paris, France
| | - Ingrid Allagbé
- Department of Psychiatry and Addictology, AP-HP. Centre, Université de Paris, Paris, France.,Fédération Hospitalo-Universitaire, Network of Research in Substance Use Disorder, AP-HP, Paris, France
| | - Guillaume Airagnes
- Department of Psychiatry and Addictology, AP-HP. Centre, Université de Paris, Paris, France.,Faculté de Médecine, Université Paris Descartes, Sorbonne Paris Cité, Paris, France.,Population-based Epidemiological Cohorts, Inserm, UMS 011, Villejuif, France.,Aging and chronic diseases, Inserm, UMR 1168, VIMA, Villejuif, France
| | - Monique Baha
- Department of Psychiatry and Addictology, AP-HP. Centre, Université de Paris, Paris, France
| | - Abdelali Boussadi
- Département d'informatique médicale, AP-HP. Centre, Université de Paris, Paris, France.,INSERM UMRs 1138, Paris, France
| | - Frédéric Limosin
- Department of Psychiatry and Addictology, AP-HP. Centre, Université de Paris, Paris, France.,Population-based Epidemiological Cohorts, Inserm, UMS 011, Villejuif, France.,Centre Psychiatrie et Neurosciences, Inserm, U894, Paris, France
| |
Collapse
|
3
|
Underner M, Perriot J, Brousse G, de Chazeron I, Schmitt A, Peiffer G, Harika-Germaneau G, Jaafari N. Arrêt et réduction du tabac chez le patient souffrant de schizophrénie. L'ENCEPHALE 2019; 45:345-356. [PMID: 31153585 DOI: 10.1016/j.encep.2019.04.067] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [Track Full Text] [Subscribe] [Scholar Register] [Received: 10/22/2018] [Revised: 04/18/2019] [Accepted: 04/22/2019] [Indexed: 02/08/2023]
|